Dymon Asia Capital »

Immunovant shares owned by Dymon Asia Capital

Quarter-by-quarter ownership of Immunovant (IMVT) shares owned by Dymon Asia Capital from 13F filings

Historical chart of Dymon Asia Capital investment in Immunovant

Tip: Access up to 7 years of quarterly data

All positions including Immunovant held by Dymon Asia Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immunovant by Dymon Asia Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $591k 24k 24.84
2025-12-31 $742k 29k 25.42
2025-09-30 $289k 18k 16.12

More positions owned by Dymon Asia Capital

State Str Spdr S&p 500 Etf T Tr Unit Call Option (SPY)
Ishares Tr Mbs Etf (MBB)
Meta Platforms Cl A (META)
NVIDIA Corporation (NVDA)
Lumentum Hldgs (LITE)
Alibaba Group Hldg Sponsored Ads (BABA)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Vaneck Etf Trust Semiconductr Etf (SMH)
Ishares Silver Tr Ishares (SLV)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Msci Sth Afr Etf Call Option (EZA)
Ishares Tr Russell 2000 Etf (IWM)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
UnitedHealth Call Option (UNH)
Microchip Technology (MCHP)

View all positions for Dymon Asia Capital

Top funds holding Immunovant

FMR
Deep Track Capital
Vanguard Group
BlackRock
Armistice Capital
Baker Bros. Advisors
T. Rowe Price Investment Management
State Street Corporation
TCG Crossover Management
Morgan Stanley
Vanguard Portfolio Management
Vanguard Capital Management
Two Seas Capital
Jennison Associates
Rtw Investments

View all funds holding Immunovant